Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1994-03-01 (32 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AUCHY-LES-MINES (62138), Pas-de-Calais
PHARMACIE PORTE DES FLANDRES : revenue, balance sheet and financial ratios
PHARMACIE PORTE DES FLANDRES is a French company
founded 32 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AUCHY-LES-MINES (62138),
this company of category PME
shows in 2023 a revenue of 2.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PORTE DES FLANDRES (SIREN 394076632)
Indicator
2025
2024
2023
2022
2021
2020
2020
2019
2018
2017
Revenue
N/C
N/C
2 720 379 €
N/C
N/C
N/C
N/C
N/C
N/C
3 001 124 €
Net income
107 535 €
94 870 €
146 705 €
106 114 €
33 289 €
122 €
-2 696 €
21 829 €
86 027 €
88 719 €
EBITDA
N/C
N/C
192 935 €
N/C
N/C
N/C
N/C
N/C
N/C
59 376 €
Net margin
N/C
N/C
5.4%
N/C
N/C
N/C
N/C
N/C
N/C
3.0%
Revenue and income statement
In 2025, PHARMACIE PORTE DES FLANDRES generates positive net income of 108 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 89 k€ -> 108 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
107 535 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 194%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
194.474%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
18.595%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE PORTE DES FLANDRES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Debt ratio
46.215
11.188
1504.769
9642.823
4160.726
936.558
173.259
154.626
214.449
194.474
Financial autonomy
43.057
53.277
4.176
0.649
1.364
5.375
18.627
20.482
15.733
18.595
Repayment capacity
1.431
None
None
None
None
None
None
1.942
None
None
Cash flow / Revenue
3.466%
None%
None%
None%
None%
None%
None%
5.468%
None%
None%
Sector positioning
Debt ratio
194.472025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of PHARMACIE PORTE DES FLANDRES (194.47) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
18.59%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE PORTE DES FLANDRES (18.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
1.94 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of PHARMACIE PORTE DES FLANDRES (1.94) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 205.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
205.269
Liquidity indicators evolution PHARMACIE PORTE DES FLANDRES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Liquidity ratio
222.913
203.569
250.578
235.408
188.163
169.179
180.902
193.346
176.993
205.269
Interest coverage
1.432
None
None
None
None
None
None
1.663
None
None
Sector positioning
Liquidity ratio
205.272025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+6 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE PORTE DES FLANDRES (205.27) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.66x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE PORTE DES FLANDRES (1.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PORTE DES FLANDRES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Operating WCR
344 889 €
0 €
0 €
0 €
0 €
0 €
0 €
770 847 €
0 €
0 €
Inventory turnover (days)
29
0
0
0
0
0
0
54
0
0
Customer payment term (days)
5
0
0
0
0
0
0
4
0
0
Supplier payment term (days)
32
0
0
0
0
0
0
63
0
0
Positioning of PHARMACIE PORTE DES FLANDRES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE PORTE DES FLANDRES is estimated at
1 708 206 €
(range 1 159 196€ - 2 680 410€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1159k€1708k€2680k€
1 708 206 €Range: 1 159 196€ - 2 680 410€
NAF 5 année 2025
Valuation method used
Net Income Multiple
107 535 €
×
15.9x
=1 708 206 €
Range: 1 159 197€ - 2 680 411€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PORTE DES FLANDRES with other companies in the same sector:
Frequently asked questions about PHARMACIE PORTE DES FLANDRES
What is the revenue of PHARMACIE PORTE DES FLANDRES ?
The revenue of PHARMACIE PORTE DES FLANDRES in 2023 is 2.7 M€.
Is PHARMACIE PORTE DES FLANDRES profitable?
Yes, PHARMACIE PORTE DES FLANDRES generated a net profit of 108 k€ in 2025.
Where is the headquarters of PHARMACIE PORTE DES FLANDRES ?
The headquarters of PHARMACIE PORTE DES FLANDRES is located in AUCHY-LES-MINES (62138), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE PORTE DES FLANDRES ?
The tax return of PHARMACIE PORTE DES FLANDRES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PORTE DES FLANDRES operate?
PHARMACIE PORTE DES FLANDRES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart